Nanomix, Inc. to Present at Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' Conference, June 21-23, 2006 in San Francisco, CA
Nanomix, Inc. (www.nano.com) was the first company to bring a nanoelectronic detection device to market and is aggressively pursuing commercialization of detection solutions for respiratory, life science, and industrial applications. Nanomix has developed an excellent intellectual property estate including over 60 patents.
As described in a recent article published in Proceedings of the National Academy of Science, Nanomix has established feasibility of nanoelectronic-based, label-free detection of DNA. This enables a wide variety of handheld, point-of-care tests for infectious disease, personalized medicine, and agricultural genetic detection.
Among the respiratory product applications, Nanomix is developing a respiratory monitor which is appropriate for hospital and pre-hospital settings, and has been optimized for Emergency Response personnel. This small, disposable device monitors varying CO2 levels. Clinical applications include endotracheal tube placement verification (critical in preventing brain damage and death from lack of oxygen), inter/intra hospital patient respiratory monitoring during transport, and monitoring the adequacy of CPR.
The commercialization of the Sensation(TM) detection platform creates a product portfolio that includes high-value detection solutions. David Macdonald, President and CEO of Nanomix, will be presenting a company overview and corporate strategy review on Friday, June 23, at 11:10 a.m. PT, at Medtech Insight and Windhover Information's "In3 Medical Device Summit" Conference at The Palace Hotel in San Francisco, CA.
Nanomix is a leading nanoelectronic detection company launching a portfolio of devices based on Sensation(TM) technology. These scaleable devices use ultra-sensitive carbon nanotube detection elements combined with proprietary chemistries. They can be deployed across a broad range of industrial and medical applications where valuable attributes -- low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit www.nano.com.
A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. The In3 Medical Device Summit (www.meddevicesummit.com) is Medtech Insight's 21st investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes at (480) 985-9512 or (888) 202-5939 toll-free in the U.S., e-mail email@example.com, or visit www.medtechinsight.com.